
北美心血管针市场预测至 2028 年 - COVID-19 影响和按类型划分的区域分析(圆形针和切割针);应用(心脏直视手术和心脏瓣膜手术);使用(单次使用和多次使用);最终用户(医院和诊所、门诊手术中心和心血管中心)
No. of Pages: 104 | Report Code: TIPRE00025905 | Category: Life Sciences
No. of Pages: 104 | Report Code: TIPRE00025905 | Category: Life Sciences
心血管针用于多种心血管手术,如心脏直视手术、心脏瓣膜手术、心脏移植、冠状动脉搭桥手术等许多手术都需要手术针。这些心血管针有两种类型:一次性或无眼针和多次使用或有眼针。心血管针由含有高浓度镍、Surgalloy 和 Ethalloy 的新型不锈钢合金制成。
因此,心血管疾病患病率的不断上升预计将在未来对心血管针产生巨大的需求预计将进一步推动心血管针市场的发展。
心脏外科患者不仅需要重要的 ICU 资源,而且还可能属于 COVID-19 并发症的最高风险类别。因此,大部分医院和外科医院都考虑取消或推迟包括心血管手术在内的择期手术。因此,预计 COVID 19 的影响将对心血管针市场产生一定程度的负面影响,但预计这种影响也是短期的。根据胸外科医生协会成人心脏手术数据库和约翰·霍普金斯大学 COVID-19 数据库,美国成人心脏手术量减少了 52.7%,择期病例减少了 65.5%。在第一次 COVID-19 激增之后,全国心脏手术病例数有所下降,这表明与 COVID-19 相关的心脏手术患者受到影响。但从长远来看,随着疫苗接种计划的确定和传播率的下降,医疗保健系统将恢复正常,对心血管针的需求将增加,这将支撑市场。
北美心血管针市场预计将从 2021 年的 30,555.0 万美元增长到 2028 年的 50,854.8 万美元;预计 2021 年至 2028 年复合年增长率为 7.5%。医疗保健和医疗器械行业在过去十年中蓬勃发展。技术进步导致大量联网医疗设备的可用性激增,并提高了它们在医疗保健中的重要性,正在彻底改变医疗设备行业。目前医疗器械的供需存在巨大缺口,这为器械制造商在该地区立足提供了重大机遇。
从类型来看,2020年,圆体针细分市场占据北美心血管针市场最大份额。从应用来看,心脏直视手术细分市场占据了2020年北美心血管针市场的最大份额。从使用情况来看,一次性使用细分市场占据了2020年北美心血管针市场的最大份额。最终用户中,医院和诊所占据了2020年北美心血管针市场的最大份额。
准备本北美心血管针市场报告时参考的一些主要一手和二手来源包括公司网站、年报、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Ethicon (Johnson & Johnson Services, Inc.)、MANI, INC.、Barber of Sheffield、FSSB 手术针 GmbH、Medtronic、Teleflex Incorporated、Meril Life Sciences Pvt.。有限公司、CP Medical 和 SMB Corporation of India。
通过申请
按用途 span>
最终用户
按国家/地区< /p>
Strategic insights for North America Cardiovascular Needle involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 30,555.0 thousand |
Market Size by 2028 | US$ 50,854.8 thousand |
Global CAGR (2021 - 2028) | 7.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Cardiovascular Needle refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Cardiovascular Needle Market is valued at US$ 30,555.0 thousand in 2021, it is projected to reach US$ 50,854.8 thousand by 2028.
As per our report North America Cardiovascular Needle Market, the market size is valued at US$ 30,555.0 thousand in 2021, projecting it to reach US$ 50,854.8 thousand by 2028. This translates to a CAGR of approximately 7.5% during the forecast period.
The North America Cardiovascular Needle Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Cardiovascular Needle Market report:
The North America Cardiovascular Needle Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Cardiovascular Needle Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Cardiovascular Needle Market value chain can benefit from the information contained in a comprehensive market report.